Diagnostic News and Research

RSS

Multicolor quantum dots can distinguish Reed-Sternberg cells, article shows

The tunable fluorescent nanoparticles known as quantum dots make ideal tools for distinguishing and identifying rare cancer cells in tissue biopsies, Emory and Georgia Tech scientists have demonstrated.

7 Jul 2010

QIAGEN receives CE conformity marking for careHPV Test

QIAGEN has completed European certification of its careHPV™ Test to bring human papillomavirus (HPV) testing to public-health programs in low-resource, developing countries, the company announced today at the International Papillomavirus Conference in Montreal, Canada. The CE conformity marking ("Conformite Europeenne") certifies that the careHPV Test has met European Union consumer safety and health requirements, allowing the test to be distributed in developing countries that recognize the CE mark.

From QIAGEN Manchester Limited 7 Jul 2010

Cambridge Heart commences enrollment in study to identify ischemia in patients with coronary artery disease

Cambridge Heart, Inc., today announced the first patient enrollments in the MTWA-CAD study (Evaluation of Microvolt T-Wave Alternans Testing for the Detection of Active Ischemia in Patients with Known or Suspected Coronary Artery Disease).

7 Jul 2010

Biomagnetics Diagnostics signs new CRADA with Los Alamos National Security

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of a new Cooperative Research and Development Agreement with Los Alamos National Security, LLC for the development of a waveguide-based integrated optical biosensor platform for the detection of disease causing pathogens.

7 Jul 2010

St. Jude Medical acquires LightLab Imaging

St. Jude Medical, Inc., a global medical device company, today completed the previously announced acquisition of LightLab Imaging, Inc. for approximately $90 million in cash.

7 Jul 2010

CPRIT grants RBM $3 million Company Commercialization Award to expand OncologyMAP program

Rules-Based Medicine, Inc. (RBM) today announced the Cancer Prevention and Research Institute of Texas (CPRIT) has granted it a Company Commercialization Award to expand and enhance the OncologyMAP™ program for discovery and development of novel diagnostic and prognostic cancer tests. The award of approximately $3 million will fund research and development to more than double the number of cancer-associated biomarker assays in RBM's new OncologyMAP™ product.

6 Jul 2010

Investment report on Imaging3

MicroStockProfit.com announces an investment report featuring Imaging3 Inc.. The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.

6 Jul 2010

Protagen, Mikrogen collaborate to identify typical autoantibody signatures in infectious diseases

Protagen AG, Dortmund, and the Neuried, Germany, based diagnostics company Mikrogen GmbH, announced today the closing of a collaboration agreement for the identification of typical autoantibody signatures in infectious diseases.

6 Jul 2010

New blood test eliminates need for surgical lung biopsy for LAM diagnosis

Researchers at the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center have found that a certain blood test can successfully identify lymphangioleiomyomatosis (LAM) in some patients, eliminating the need for surgical lung biopsy to make a diagnosis.

6 Jul 2010

Infoway adds diagnostic imaging, drug information systems to Certification Services

Canada Health Infoway has added diagnostic imaging and drug information systems to its pre-implementation Certification Services. Health information technology vendors can now receive certification for seven classes of technology.

6 Jul 2010

Anxiety disorders associated with higher risk of cardiovascular events, deaths in heart disease patients

Among patients with heart disease, anxiety disorders appear to be associated with a higher risk of stroke, heart attack, heart failure and death, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

6 Jul 2010

Synexus expands clinical trial operations in Gydnia, Poland

Synexus, the world's largest multi-national company dedicated to the recruitment and running of clinical trials is expanding its operations in Gydnia, Poland when it moves to new premises later this year. It has also recently increased the capacity of its original centre in Wroclaw by several hundred square metres.

From AES - Accelerated Enrollment Solutions 5 Jul 2010

Metabolon unveils novel approach to identify patients at preterm delivery risk

Metabolon, Inc., the leader in global metabolism, biomarker discovery and analysis, announces the publication of "Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery", in The Journal of Maternal-Fetal and Neonatal Medicine.

3 Jul 2010

CNA Healthpro releases toolkit to enhance resident safety, minimize organizational risk in aging services

CNA recognizes the importance of patient/resident safety and risk management in the evolving world of healthcare. As one of the nation's leading providers of professional liability insurance for healthcare providers and organizations, CNA HealthPro recently published a risk management toolkit, "Special Resource: Protecting Residents, Reducing Liability Exposure - An Aging Services Resource from CNA HealthPro," which offers guidance on clinical, operational, and strategic subjects of concern to aging services providers.

3 Jul 2010

Neogenix Oncology files patent application with USPTO for 16C3 antigen

Neogenix Oncology announced today that the company has filed a patent application with the U.S. Patent and Trade Office (USPTO) for the 16C3 antigen. The Company believes that this antigen is tumor specific for pancreatic and colorectal tumors; and, based on preliminary clinical data, may also have diagnostic utility as a biomarker for these cancers.

3 Jul 2010

Over 28,000 patients access myMDAnderson web-based portal for personal health information in one year

Just one year after The University of Texas MD Anderson Cancer Center launched its secured, Web-based portal for personal health information, more than 28,000 patients (57 percent) who logged into myMDAnderson - a personalized, online connection to the center - have accessed their personal medical information, test results and records.

2 Jul 2010

SNMTS honors contributions in nuclear medicine and molecular imaging at 57th Annual Meeting

SNM's Technologist Section (SNMTS)-an international scientific and medical organization-recognized the contributions and work to the field of nuclear medicine and molecular imaging during its 57th Annual Meeting in Salt Lake City. Several awards ceremonies were held to recognize the value that SNMTS members play in advancing the diagnosis and treatment of heart disease, cancer and neurological conditions.

2 Jul 2010

BIDMC calls for new training program for personalized healthcare

The Department of Pathology at Beth Israel Deaconess Medical Center (BIDMC) have issued "A Call to Action" for the medical profession to catch up with the technology and business communities in the application of genomics to personalized health care.

2 Jul 2010

New MRI technology may revolutionize diagnosis of medical conditions

The development of a new magnetic resonance imaging technology that could revolutionise the way medical conditions are diagnosed and treated is to take a major step forward as a £7m research centre is established at the University of York.

2 Jul 2010

Diagnostic Hybrids receives Chinese SFDA approval for D3 Ultra DFA Respiratory Virus Screening and ID Kit

Diagnostic Hybrids, a Quidel Company, received approval from the People's Republic of China's State Food and Drug Administration (SFDA) for its D3 Ultra DFA Respiratory Virus Screening and ID Kit. The D3 Ultra DFA Respiratory Virus Screening and ID Kit is a direct fluorescence assay (DFA) that provides rapid, sensitive and specific screening and identification of Influenza A, Influenza B, Parainfluenza 1, 2, & 3, Respiratory Syncytial Virus and Adenovirus.

1 Jul 2010

Diagnostic News and Research

Multicolor quantum dots can distinguish Reed-Sternberg cells, article shows

QIAGEN receives CE conformity marking for careHPV Test

Cambridge Heart commences enrollment in study to identify ischemia in patients with coronary artery disease

Biomagnetics Diagnostics signs new CRADA with Los Alamos National Security

St. Jude Medical acquires LightLab Imaging

CPRIT grants RBM $3 million Company Commercialization Award to expand OncologyMAP program

Investment report on Imaging3

Protagen, Mikrogen collaborate to identify typical autoantibody signatures in infectious diseases

New blood test eliminates need for surgical lung biopsy for LAM diagnosis

Infoway adds diagnostic imaging, drug information systems to Certification Services

Anxiety disorders associated with higher risk of cardiovascular events, deaths in heart disease patients

Synexus expands clinical trial operations in Gydnia, Poland

Metabolon unveils novel approach to identify patients at preterm delivery risk

CNA Healthpro releases toolkit to enhance resident safety, minimize organizational risk in aging services

Neogenix Oncology files patent application with USPTO for 16C3 antigen

Over 28,000 patients access myMDAnderson web-based portal for personal health information in one year

SNMTS honors contributions in nuclear medicine and molecular imaging at 57th Annual Meeting

BIDMC calls for new training program for personalized healthcare

New MRI technology may revolutionize diagnosis of medical conditions

Diagnostic Hybrids receives Chinese SFDA approval for D3 Ultra DFA Respiratory Virus Screening and ID Kit

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News